ArticleFrontiers in medicine2021

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19.

Mar Masiá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.